β-Selective C-Arylation of Diisobutylaluminum Hydride Modified 1,6-Anhydroglucose: Synthesis of Canagliflozin without
Julian P Henschke1, Chen-Wei Lin1, Ping-Yu Wu1
1‡Department of Exploratory Research and §Department of Analytical Research and Development, ScinoPharm Taiwan, No. 1, NanKe 8th Road, Tainan Science-Based Industrial Park, ShanHua, Tainan, 74144 Tainan County, Taiwan.
A new method enables direct phenylation of unprotected 1,6-anhydroglucose, simplifying synthesis. This approach avoids protecting groups and is used to create the SGLT2 inhibitor canagliflozin.
Area of Science:
- Organic Chemistry
- Carbohydrate Chemistry
- Medicinal Chemistry
Background:
- 1,6-anhydroglucose is a valuable carbohydrate building block.
- Conventional synthesis of derivatives often requires protecting groups, adding steps and complexity.
- Developing efficient C-C bond-forming reactions is crucial for synthesizing complex molecules.
Purpose of the Study:
- To report a novel β-selective phenylation method for 1,6-anhydroglucose.
- To demonstrate the direct phenylation of unprotected 1,6-anhydroglucose.
- To showcase the utility of this method in synthesizing pharmaceutical compounds.
Main Methods:
- Phenylation of protected and unprotected 1,6-anhydroglucose using triphenylalane or aryl(chloro)alanes.
- Pretreatment of unprotected 1,6-anhydroglucose with various aluminum alkyls (e.g., i-Bu2AlH, Et3Al).
- Synthesis of canagliflozin via a one-step C-C bond-forming reaction.
Main Results:
- Successful β-selective phenylation of both protected and unprotected 1,6-anhydroglucose.
- Demonstration of direct phenylation on unprotected 1,6-anhydroglucose using aluminum alkyl pretreatment.
- Efficient one-step synthesis of canagliflozin (a SGLT2 inhibitor) from unprotected 1,6-anhydroglucose.
Conclusions:
- A novel, protecting-group-free method for the phenylation of 1,6-anhydroglucose has been developed.
- This direct phenylation strategy significantly streamlines synthetic routes.
- The method provides a more efficient pathway to important pharmaceutical agents like canagliflozin.
Related Concept Videos
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Sulfonylureas
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Glinides


